Showing 1 - 10 of 14
A tanulmány célja az értékpapírok esetében leggyakrabban alkalmazott két aukciós technika (az egyenáras és a diszkriminatív áras aukció) összehasonlító elemzése. A szakirodalom elsősorban az aukció várható bevétele szempontjából elemzi a módszereket. Az elméleti...
Persistent link: https://www.econbiz.de/10015241420
This survey reviews the economic thoughts about what and why do institutional market players lose because of the existing market frictions and particular financial market microstructures compared to walrasian markets. Within a unified microeconomic framework, we introduce the most common...
Persistent link: https://www.econbiz.de/10010494600
This survey reviews the economic thoughts about what and why do institutional market players lose because of the existing market frictions and particular financial market microstructures compared to walrasian markets. Within a unified microeconomic framework, we introduce the most common...
Persistent link: https://www.econbiz.de/10010402552
We analyze the problem of a jury choosing the winner from a set of agents when the identity of the deserving winner is common knowledge amongst the jurors but each juror is biased in favor of one di¤erent agent. We propose a simple and natural mechanism that implements the socially optimal rule...
Persistent link: https://www.econbiz.de/10008486381
Az agrárkutatás-oktatás kiemelt társadalmi feladat. Az innováció olyan tudatos emberi tevékenység, amely a technikai-gazdasági fejlesztések minden területére kiterjed, s célja új javak és szolgáltatások új módon történő előállítása a tudomány eredményeinek közvetlen...
Persistent link: https://www.econbiz.de/10009446965
One-sector R&D-based models predict scale effects, which is empirically inconsistent. This is due to the "knife-edge" assumption that new ideas created are linear in the stock of knowledge. If this assumption is dropped to make a one-sector R&D-based model consistent with data, growth becomes...
Persistent link: https://www.econbiz.de/10005398525
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals from 1 January, 2005. WIll this lead increase in resources deveoted to R and D by Indian companies for the development of new drugs more suited to the needs of India and other...
Persistent link: https://www.econbiz.de/10004988399
Persistent link: https://www.econbiz.de/10001352757
Persistent link: https://www.econbiz.de/10001246800